Pete Ecclestone

Pete Ecclestone is an accomplished professional in business development within the pharmaceutical and biotech industries, currently serving as Head of Business Development at Pendopharm. Previously, Pete held leadership and consulting roles at notable companies such as Valeo Pharma, Aralez Pharmaceuticals, and Mylan, where strategic initiatives in licensing, acquisitions, and operational execution were successfully completed. Additionally, expertise in market research and sales operations was demonstrated during tenure at Abbott Laboratories and Solvay Pharmaceuticals. Pete holds a Bachelor of Science degree in Pharmacology and Biology from McMaster University.